Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hunniwell Lake Ventures is a venture capital firm based in Palo Alto, California, founded in 2019 by Richard Fang and Daniel Teo. The firm focuses on investing in medical device companies, particularly those developing innovations to improve surgical procedures and patient outcomes. Hunniwell Lake Ventures operates with a concentrated strategy, aiming to support 15-20 portfolio companies, which allows for a more hands-on approach to each investment.
The firm leverages an extensive international network, particularly in the Chinese market, to facilitate market access and profitability for its portfolio companies. This strategic positioning enables Hunniwell Lake Ventures to provide significant value beyond capital, enhancing the commercialization process for its investments.
Notable milestones include participation in significant funding rounds, such as a $7 million Series B for CoapTech, and the upcoming public listing of Picard Medical, Inc. through a merger with Altitude Acquisition Corp. The firm continues to expand its influence in the medical device sector, focusing on innovations that make surgery safer and more accessible.
Hunniwell Lake Ventures specializes in investing in medical device companies, particularly those that extend proven technologies within overlooked segments. The firm emphasizes innovations that reduce technology, regulatory approval, and market adoption risks. Their investment strategy is particularly focused on surgical visualization, electrosurgical technologies, and post-operative healing.
Investments are typically made in companies at the imminent or early revenue stage, with check sizes reaching up to $5 million. Hunniwell Lake Ventures seeks to partner with entrepreneurs who have existing products and sales teams, as well as those capable of leveraging strategic partnerships for rapid scaling. The firm’s thesis is centered on making surgery safer, more accessible, and less invasive, aligning with their focus on enhancing patient outcomes through innovative medical devices.
Hunniwell Lake Ventures has a diverse portfolio of 20 companies, primarily in the medical device sector. Notable portfolio companies include:
These companies exemplify Hunniwell Lake Ventures' commitment to investing in innovations that improve surgical procedures and patient outcomes. The firm actively supports its portfolio through strategic partnerships and market access initiatives, particularly in the Chinese market.
Richard Fang: Managing Partner and Founder; previously CEO of Reach Surgical, overseeing operations across six continents. He has extensive experience in the medical device industry and a strong background in surgical instruments.
Daniel Teo: Managing Partner and Founder; former CFO of Reach Surgical, where he led international business and joint venture establishment. He brings financial expertise and strategic insight to the firm.
David Schechter: Operating Partner; has a wealth of experience in operational management within the medical device sector, focusing on enhancing portfolio company performance.
John Ashley: Entrepreneur-in-Residence; provides mentorship and guidance to portfolio companies, leveraging his extensive entrepreneurial background.
David Yeow: Principal; involved in sourcing and evaluating investment opportunities, with a focus on medical device innovations.
Matthew Otten: Operations Consultant; supports portfolio companies in operational efficiency and scaling strategies.
To pitch to Hunniwell Lake Ventures, founders should use the email address bp@hunniwell.com. It is recommended to include a comprehensive deck that outlines the business model, technology, market analysis, and team qualifications. The firm appreciates detailed information on how the innovation addresses specific clinical needs and the competitive landscape.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
Hunniwell Lake Ventures hosts the F50 Hunniwell Medical Device Forum, an industry event aimed at fostering connections within the medical device sector.
In recent activity, Hunniwell Lake Ventures participated in a $7 million Series B funding round for CoapTech, which is developing the Pediatric PUMA-G System for less invasive feeding tube placement. This investment highlights the firm's commitment to supporting innovative medical device companies.
Additionally, Picard Medical, Inc. is preparing for a public listing through a merger with Altitude Acquisition Corp., marking a significant milestone for both the company and Hunniwell Lake Ventures.
Hunniwell Lake Ventures continues to engage in industry events, such as the F50 Global Capital Summit, which focuses on health tech innovation, further solidifying its presence in the medical device sector.
What are Hunniwell Lake Ventures' investment criteria?
The firm invests exclusively in medical device companies at the imminent or early revenue stage. They focus on innovations that reduce technology, regulatory approval, and market adoption risks, particularly in surgical visualization, electrosurgical technologies, and post-operative healing.
How can I apply or pitch to Hunniwell Lake Ventures?
Founders can pitch their business plans via email at bp@hunniwell.com. It is advisable to include a detailed overview of the technology, market potential, and team background in the pitch.
What makes Hunniwell Lake Ventures different from other VC firms?
Hunniwell Lake Ventures differentiates itself through its concentrated investment strategy, focusing on a limited number of portfolio companies to provide tailored support. Their founders' existing distribution network and strategic partnerships, particularly in China, enhance commercialization opportunities for their investments.
What is the geographic scope of Hunniwell Lake Ventures?
The firm primarily invests in North America but leverages its network to access markets in China, facilitating international growth for its portfolio companies.
What is the typical check size for investments?
Hunniwell Lake Ventures typically invests up to $5 million per company, focusing on providing sufficient capital to support growth and development.
What kind of post-investment involvement does Hunniwell Lake Ventures have?
The firm actively engages with its portfolio companies, providing access to their extensive network and strategic partnerships to accelerate commercialization and market access.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.